Top

European Radiology

Published in:

01-11-2010 | Magnetic Resonance

Comparison of gadolinium-EOB-DTPA-enhanced and diffusion-weighted liver MRI for detection of small hepatic metastases

Authors: Kotaro Shimada, Hiroyoshi Isoda, Yuusuke Hirokawa, Shigeki Arizono, Toshiya Shibata, Kaori Togashi

Published in: European Radiology | Issue 11/2010

Abstract

Objective

To compare the accuracy of gadolinium ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced MRI with that of diffusion-weighted MRI (DWI) in the detection of small hepatic metastases (2 cm or smaller).

Methods

Forty-five patients underwent abdominal MRI at 3 T, including T1-weighted imaging (T1WI), T2-weighted imaging (T2WI), heavily T2WI (HASTE), DWI with a b-value of 500 s/mm² and contrast-enhanced MRI with Gd-EOB-DTPA. Two groups were assigned and compared: group A (T1WI, T2WI, HASTE and contrast-enhanced study with Gd-EOB-DTPA), and group B (T1WI, T2WI, HASTE and DWI). Two observers independently interpreted the images obtained in a random order. For all hepatic metastases, the diagnostic performance using each imaging set was evaluated by receiver-operating characteristic (ROC) curve analysis.

Results

A total of 51 hepatic metastases were confirmed. The area under the ROC curve (Az) of group A was larger than that of group B, and the difference in the mean Az values between the two image sets was statistically significant, whereas, there were three metastases that lay near thin vessels or among multiple cysts and were better visualised in group B than in group A.

Conclusion

Gd-EOB-DTPA-enhanced MRI showed higher accuracy in the detection of small metastases than DWI.

Hamm B, Staks T, Muhler A et al (1995) Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 195:785–792PubMed

Vogl TJ, Kummel S, Hammerstingl R et al (1996) Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology 200:59–67PubMed

Reimer P, Rummeny EJ, Shamsi K et al (1996) Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. Radiology 199:177–183PubMed

Zech CJ, Herrmann KA, Reiser MF et al (2007) MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA. Magn Reson Med Sci 6:43–52CrossRefPubMed

Ichikawa T, Haradome H, Hachiya J et al (1998) Diffusion-weighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions. AJR Am J Roentgenol 170:397–402PubMed

Xu PJ, Yan FH, Wang JH et al (2009) Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis. J Magn Reson Imaging 29:341–349CrossRefPubMed

Fukatsu H (2003) 3T MR for clinical use: update. Magn Reson Med Sci 2:37–45CrossRefPubMed

Naganawa S, Sato C, Nakamura T et al (2005) Diffusion-weighted images of the liver: comparison of tumor detection before and after contrast enhancement with superparamagnetic iron oxide. J Magn Reson Imaging 21:836–840CrossRefPubMed

Nasu K, Kuroki Y, Nawano S et al (2006) Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging. Radiology 239:122–130CrossRefPubMed

10.

No authors (2000) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 284:3043–3045

11.

van Persijn van Meerten EL, Gelderblom H, Bloem JL (2009) RECIST revised: implications for the radiologist. A review article on the modified RECIST guideline. Eur Radiol. doi:10.1007/s00330-009-1685-y [Epub ahead of print]PubMed

12.

Mathieu D, Vilgrain V, Mahfouz A et al (1997) Benign liver tumors. Magn Reson Imaging Clin N Am 5:255–288PubMed

13.

Mortele KJ, Ros PR (2001) Cystic focal liver lesions in the adult: differential CT and MR imaging features. Radiographics 21:895–910PubMed

14.

Horton KM, Bluemke DA, Hruban RH et al (1999) CT and MR imaging of benign hepatic and biliary tumors. Radiographics 19:431–451PubMed

15.

Kim T, Federle MP, Baron RL et al (2001) Discrimination of small hepatic hemangiomas from hypervascular malignant tumors smaller than 3 cm with three-phase helical CT. Radiology 219:699–706PubMed

16.

Pedro MS, Semelka RC, Braga L (2002) MR imaging of hepatic metastases. Magn Reson Imaging Clin N Am 10:15–29CrossRefPubMed

17.

Danet IM, Semelka RC, Leonardou P et al (2003) Spectrum of MRI appearances of untreated metastases of the liver. AJR Am J Roentgenol 181:809–817PubMed

18.

Low RN, Gurney J (2007) Diffusion-weighted MRI (DWI) in the oncology patient: value of breathhold DWI compared to unenhanced and gadolinium-enhanced MRI. J Magn Reson Imaging 25:848–858CrossRefPubMed

19.

Huppertz A, Balzer T, Blakeborough A et al (2004) Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology 230:266–275CrossRefPubMed

20.

Bluemke DA, Sahani D, Amendola M et al (2005) Efficacy and safety of MR imaging with liver-specific contrast agent: US multicenter phase III study. Radiology 237:89–98CrossRefPubMed

21.

Zech CJ, Schoenberg SO, Herrmann KA et al (2004) Modern visualization of the liver with MRT. Current trends and future perspectives. Radiologe 44:1160–1169CrossRefPubMed

22.

Onishi H, Murakami T, Kim T et al (2006) Hepatic metastases: detection with multi-detector row CT, SPIO-enhanced MR imaging, and both techniques combined. Radiology 239:131–138CrossRefPubMed

23.

Huppertz A, Balzer T, Blakeborough A et al (2004) European EOB Study Group. Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology 230:266–275CrossRefPubMed

24.

Bluemke DA, Sahani D, Amendola M et al (2005) Efficacy and safety of MR imaging with liver-specific contrast agent: US multicenter phase III study. Radiology 237:89–98CrossRefPubMed

25.

Vossen JA, Buijs M, Geschwind JF et al (2009) Diffusion-weighted and Gd-EOB-DTPA-contrast-enhanced magnetic resonance imaging for characterization of tumor necrosis in an animal model. J Comput Assist Tomogr 33:626–630CrossRefPubMed

26.

Choi JS, Kim MJ, Choi JY et al (2009) Diffusion-weighted MR imaging of liver on 3.0-Tesla system: effect of intravenous administration of gadoxetic acid disodium. Eur Radiol. doi:10.1007/s00330-009-1651-8 [Epub ahead of print]

Title: Comparison of gadolinium-EOB-DTPA-enhanced and diffusion-weighted liver MRI for detection of small hepatic metastases
Authors: Kotaro Shimada
Hiroyoshi Isoda
Yuusuke Hirokawa
Shigeki Arizono
Toshiya Shibata
Kaori Togashi
Publication date: 01-11-2010
Publisher: Springer-Verlag
Published in: European Radiology / Issue 11/2010
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-010-1842-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Comparison of gadolinium-EOB-DTPA-enhanced and diffusion-weighted liver MRI for detection of small hepatic metastases

Abstract

Objective

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 11/2010

Recent literature

Modern dental imaging: a review of the current technology and clinical applications in dental practice

Multiparameter MRI assessment of normal-appearing and diseased vertebral bone marrow

Accuracy of core-needle biopsy after contrast-enhanced ultrasound in soft-tissue tumours

Longitudinal study of a mouse model of chronic pulmonary inflammation using breath hold gated micro-CT

High-pitch dual-source CT coronary angiography: systolic data acquisition at high heart rates